These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 25770756

  • 1. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
    Zhang Y, Xu RX, Li S, Zhu CG, Guo YL, Sun J, Li JJ.
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
    [Abstract] [Full Text] [Related]

  • 2. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S, Xu RX, Guo YL, Zhang Y, Zhu CG, Sun J, Li JJ.
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [Abstract] [Full Text] [Related]

  • 3. Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX, Li S, Zhang Y, Li XL, Guo YL, Zhu CG, Li JJ.
    Lipids Health Dis; 2014 Dec 11; 13():188. PubMed ID: 25496400
    [Abstract] [Full Text] [Related]

  • 4. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC, Konrad RJ, van Himbergen TM, Isaacs A, Otokozawa S, Troutt JS, Schaefer EJ, van Greevenbroek MM, Stalenhoef AF, de Graaf J.
    Nutr Metab Cardiovasc Dis; 2013 Nov 11; 23(11):1115-21. PubMed ID: 23333725
    [Abstract] [Full Text] [Related]

  • 5. Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.
    Li S, Xu RX, Zhang Y, Guo YL, Zhu CG, Liu G, Dong Q, Li JJ.
    J Endocrinol Invest; 2015 Dec 11; 38(12):1291-9. PubMed ID: 26003826
    [Abstract] [Full Text] [Related]

  • 6. Novel circulating lipid measurements for current dyslipidemias in non-treated patients undergoing coronary angiography: PCSK9, apoC3 and sdLDL-C.
    Li S, Zhao X, Zhang Y, Zhu CG, Guo YL, Wu NQ, Xu RX, Qing P, Gao Y, Sun J, Liu G, Dong Q, Li JJ.
    Oncotarget; 2017 Feb 14; 8(7):12333-12341. PubMed ID: 27713142
    [Abstract] [Full Text] [Related]

  • 7. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
    Guardiola M, Plana N, Ibarretxe D, Cabré A, González M, Ribalta J, Masana L.
    Clin Sci (Lond); 2015 Jun 14; 128(12):877-82. PubMed ID: 25649668
    [Abstract] [Full Text] [Related]

  • 8. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
    Li S, Zhang Y, Xu RX, Guo YL, Zhu CG, Wu NQ, Qing P, Liu G, Dong Q, Li JJ.
    Ann Med; 2015 Jun 14; 47(5):386-93. PubMed ID: 26153823
    [Abstract] [Full Text] [Related]

  • 9. Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease.
    Zhang Y, Zhu CG, Xu RX, Li S, Guo YL, Sun J, Li JJ.
    J Clin Lipidol; 2014 Jun 14; 8(5):494-500. PubMed ID: 25234562
    [Abstract] [Full Text] [Related]

  • 10. Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease.
    Li S, Guo YL, Xu RX, Zhang Y, Zhu CG, Sun J, Qing P, Wu NQ, Jiang LX, Li JJ.
    Atherosclerosis; 2014 Jun 14; 234(2):441-5. PubMed ID: 24769476
    [Abstract] [Full Text] [Related]

  • 11. Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.
    Zhu YM, Anderson TJ, Sikdar K, Fung M, McQueen MJ, Lonn EM, Verma S.
    Arterioscler Thromb Vasc Biol; 2015 Oct 14; 35(10):2254-9. PubMed ID: 26293463
    [Abstract] [Full Text] [Related]

  • 12. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P, Stenman UH, Gylling H.
    Clin Sci (Lond); 2015 Sep 14; 129(5):439-46. PubMed ID: 25857271
    [Abstract] [Full Text] [Related]

  • 13. The relationship between the plasma PCSK9 levels and platelet indices in patients with stable coronary artery disease.
    Li S, Zhu CG, Guo YL, Xu RX, Zhang Y, Sun J, Li JJ.
    J Atheroscler Thromb; 2015 Sep 14; 22(1):76-84. PubMed ID: 25185779
    [Abstract] [Full Text] [Related]

  • 14. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
    Constantinides A, Kappelle PJ, Lambert G, Dullaart RP.
    Arch Med Res; 2012 Jan 14; 43(1):11-4. PubMed ID: 22300679
    [Abstract] [Full Text] [Related]

  • 15. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.
    Nekaies Y, Baudin B, Kelbousi S, Sakly M, Attia N.
    J Diabetes Complications; 2015 Jan 14; 29(8):1165-70. PubMed ID: 26412029
    [Abstract] [Full Text] [Related]

  • 16. Plasma PCSK9 in nephrotic syndrome and in peritoneal dialysis: a cross-sectional study.
    Jin K, Park BS, Kim YW, Vaziri ND.
    Am J Kidney Dis; 2014 Apr 14; 63(4):584-9. PubMed ID: 24315769
    [Abstract] [Full Text] [Related]

  • 17. Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies.
    Almontashiri NA, Vilmundarson RO, Ghasemzadeh N, Dandona S, Roberts R, Quyyumi AA, Chen HH, Stewart AF.
    PLoS One; 2014 Apr 14; 9(9):e106294. PubMed ID: 25180781
    [Abstract] [Full Text] [Related]

  • 18. Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials.
    Sahebkar A, Simental-Mendía LE, Guerrero-Romero F, Golledge J, Watts GF.
    Diabetes Obes Metab; 2015 Nov 14; 17(11):1042-55. PubMed ID: 26183252
    [Abstract] [Full Text] [Related]

  • 19. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.
    Werner C, Hoffmann MM, Winkler K, Böhm M, Laufs U.
    Vascul Pharmacol; 2014 Aug 14; 62(2):94-102. PubMed ID: 24685817
    [Abstract] [Full Text] [Related]

  • 20. Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants.
    Araki S, Suga S, Miyake F, Ichikawa S, Kinjo T, Yamamoto Y, Kusuhara K.
    Early Hum Dev; 2014 Oct 14; 90(10):607-11. PubMed ID: 25134067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.